SQL 6.6 (+0%)
US81734C1062Medical Diagnostics & ResearchDiagnostics & Research

SeqLL (SQL) Competitor Comparison

We are evaluating the key criteria listed to compare SeqLL (SQL) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - SQL ranking 53 / 58

These are the competitors of SeqLL in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
93.13
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. DarioHealth DRIO
31.71
4. Syneos Health SYNH
24.79
5. Myriad Genetics MYGN
19.68
6. CareDx CDNA
19.12
7. Heska HSKA
15.42
8. Inotiv NOTV
15.37
9. Anixa Biosciences ANIX
14.98
10. NeoGenomics NEO
10.13
11. Olink Holding OLK
8.53
12. Fulgent Genetics FLGT
8.53
13. Pacific Biosciences of California PACB
7.89
14. Exact Sciences EXAS
7.58
15. Charles River Laboratories CRL
7.2
16. DexCom DXCM
6.54
17. Aspira Womens Health AWH
5.9
18. Trinity Biotech TRIB
5.19
19. PerkinElmer PKI
4.97
20. Qiagen QGEN
4.65
21. Guardant Health GH
4.5
22. Twist Bioscience TWST
4.5
23. Neogen NEOG
4.48
24. Laboratory Corp of America Holdings LH
4.45
25. Illumina ILMN
4.44
26. Quest Diagnostics DGX
4.36
27. Personalis PSNL
4.27
28. Sotera Health SHC
4.27
29. IQVIA Holdings IQV
3.99
30. National Research NRC
3.36
31. IDEXX Laboratories IDXX
3.35
32. Bioventus BVS
3.21
33. Waters WAT
3.08
34. Sera Prognostics SERA
3.08
35. Enzo Biochem ENZ
2.94
36. Exagen XGN
2.74
37. Psychemedics PMD
2.66
38. Agilent Technologies A
2.54
39. Neuronetics STIM
2.28
40. Interpace Biosciences IDXG
2.26
41. Global Cord Blood CO
2.23
42. Precipio PRPO
2.23
43. Thermo Fisher Scientific TMO
2.15
44. Mettler-Toledo MTD
2.08
45. MaxCyte MXCT
2.06
46. MDxHealth MDXH
2.05
47. Icon ICLR
2.04
48. Biodesix BDSX
1.97
49. Danaher DHR
1.97
50. Prenetics Global PRE
1.83
51. bioAffinity Technologies BIAF
1.65
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.75
56. Medpace Holdings MEDP
0.54
57. RadNet RDNT
0.36
58. Lantheus Holdings LNTH
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.